- Companies
- Tınaztepe Sağlık
Tınaztepe Sağlık Valuation Multiples
Tınaztepe Sağlık is valued at $234M as of September 2026, a 3.1x revenue multiple. In the last fiscal year, Tınaztepe Sağlık revenue was $70M and Tınaztepe Sağlık EBITDA was $22M.
Tınaztepe Sağlık Overview
About Tınaztepe Sağlık
Tapdi Oksijen Ozel Saglik ve Egitim Hizlmetleri Sanayi Ticaret AS operates in the general medical and surgical hospitals sector. The company provides service in İzmir with a medical center and two full fledged hospitals.
Founded
2001
HQ
Employees
N/A
Website
Sectors
Financials (Last FY)
EV
$218M
Valuation Multiples
Start free trialTınaztepe Sağlık Financials
Tınaztepe Sağlık reported last fiscal year revenue of $70M and EBITDA of $22M.
In the same fiscal year, Tınaztepe Sağlık generated $29M in gross profit, $22M in EBITDA, and $14M in net income.
Tınaztepe Sağlık P&L
In the most recent fiscal year, Tınaztepe Sağlık reported revenue of $70M and EBITDA of $22M.
Tınaztepe Sağlık is profitable as of last fiscal year, with gross margin of 41%, EBITDA margin of 31%, and net margin of 20%.
Financial data powered by Morningstar, Inc.
Tınaztepe Sağlık Stock Performance
Tınaztepe Sağlık has current market cap of $234M, and enterprise value of $218M.
Tınaztepe Sağlık's stock price is $0.59.
Tınaztepe Sağlık has an EPS (earnings per share) of $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $218M | $234M | -0.7% | - | - | - | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTınaztepe Sağlık Valuation Multiples
Tınaztepe Sağlık trades at 3.1x EV/Revenue multiple, and 10.1x EV/EBITDA.
Tınaztepe Sağlık Financial Valuation Multiples
As of September 24, 2026, Tınaztepe Sağlık has market cap of $234M and EV of $218M.
Tınaztepe Sağlık has a P/E ratio of 16.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Tınaztepe Sağlık Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Tınaztepe Sağlık Margins & Growth Rates
In the most recent fiscal year, Tınaztepe Sağlık reported gross margin of 41%, EBITDA margin of 31%, and net margin of 20%.
Tınaztepe Sağlık Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Tınaztepe Sağlık Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Tınaztepe Sağlık Competitors
Tınaztepe Sağlık competitors include Atrys Health, Monash IVF Group, Oncoclínicas, Suraksha Diagnostics, Pihlajalinna, Goodwill Pharma, Limes Schlosskliniken, Medica Sur, MediClin and Shalby.
Most Tınaztepe Sağlık public comparables operate across Hospitals & Clinics.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $161M | ($12M) | 2.3x | 2.1x | (30.3x) | 13.3x | |||
| $193M | $46M | 1.8x | 1.8x | 7.4x | 8.9x | |||
| $1.1B | ($438M) | 0.9x | 0.9x | (2.3x) | 7.3x | |||
| $32M | $10M | 6.3x | 5.8x | 20.4x | 18.4x | |||
| $747M | $125M | 0.6x | 0.7x | 3.9x | 4.2x | |||
| $72M | $19M | 2.9x | - | 11.2x | - | |||
| $57M | $15M | 3.2x | 2.7x | 12.6x | 10.9x | |||
| $276M | $57M | 0.9x | 1.0x | 4.6x | 4.7x | |||
This data is available for Pro users. Sign up to see all Tınaztepe Sağlık competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Tınaztepe Sağlık
| When was Tınaztepe Sağlık founded? | Tınaztepe Sağlık was founded in 2001. |
| Where is Tınaztepe Sağlık headquartered? | Tınaztepe Sağlık is headquartered in Turkey. |
| Is Tınaztepe Sağlık publicly listed? | Yes, Tınaztepe Sağlık is a public company listed on Borsa Istanbul. |
| What is the stock symbol of Tınaztepe Sağlık? | Tınaztepe Sağlık trades under TNZTP ticker. |
| When did Tınaztepe Sağlık go public? | Tınaztepe Sağlık went public in 2023. |
| Who are competitors of Tınaztepe Sağlık? | Tınaztepe Sağlık main competitors include Atrys Health, Monash IVF Group, Oncoclínicas, Suraksha Diagnostics, Pihlajalinna, Goodwill Pharma, Limes Schlosskliniken, Medica Sur, MediClin, Shalby. |
| What is the current market cap of Tınaztepe Sağlık? | Tınaztepe Sağlık's current market cap is $234M. |
| What is the current revenue of Tınaztepe Sağlık? | Tınaztepe Sağlık's last fiscal year revenue is $70M. |
| What is the current EV/Revenue multiple of Tınaztepe Sağlık? | Current revenue multiple of Tınaztepe Sağlık is 3.1x. |
| Is Tınaztepe Sağlık profitable? | No, Tınaztepe Sağlık is not profitable. |
| How many companies Tınaztepe Sağlık has acquired to date? | Tınaztepe Sağlık hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Tınaztepe Sağlık has invested to date? | Tınaztepe Sağlık hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Tınaztepe Sağlık
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




